117 related articles for article (PubMed ID: 933811)
1. [Effect of heparin, aggregation inhibitors and vasoactive substances on chronic-obliterative vascular diseases].
Wenzel E; Nienhaus KH; Bahre G; Holzhüter H; Angelkort B; Meyer-Erkelenz
Med Welt; 1976 Jun; 27(25):1242-7. PubMed ID: 933811
[No Abstract] [Full Text] [Related]
2. [Drug treatment of retinal degeneration of vascular origin].
Klíma M; Jebavá R; Skalová D
Cesk Oftalmol; 1971 Sep; 27(5):309-14. PubMed ID: 5110677
[No Abstract] [Full Text] [Related]
3. Protracted use of dicoumarol anticoagulants in the treatment of peripheral arteriopathies.
Raso AM; Roviera C; Scevola G
Panminerva Med; 1975; 16(7-8):238-45. PubMed ID: 45868
[No Abstract] [Full Text] [Related]
4. [Medicinal prevention and therapy of arterial occlusive diseases of the extremities].
Hild R
Dtsch Med J; 1967 May; 18(10):306-12. PubMed ID: 5612094
[No Abstract] [Full Text] [Related]
5. [Is it possible to modify labyrinthine circulation?].
Martin H; Martin C; Oudot J
J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1978 May; 27(5):331-9. PubMed ID: 149834
[No Abstract] [Full Text] [Related]
6. [On the comparative results of the use of Clarisco in peripheral vascular diseases].
Vittori C; Borri P; Bianchi V
Minerva Med; 1970 Dec; (97 Suppl):5585-640. PubMed ID: 4250224
[No Abstract] [Full Text] [Related]
7. [Intra-femoral artery injections in a hospital angiology clinic].
Griton P
Phlebologie; 1979; 32(1):47-52. PubMed ID: 432289
[TBL] [Abstract][Full Text] [Related]
8. [Longterm treatment of POAD with anticoagulants and platelet inhibitors after endovascular procedures and vascular surgery: what is evidence based?].
Landgraf H
Hamostaseologie; 2006 Aug; 26(3):239-44; quiz 245-6. PubMed ID: 16906242
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of acute arterial and venous obstructions].
Nicolosi G
Recenti Prog Med; 1970 Jun; 48(6):503-28. PubMed ID: 5536682
[No Abstract] [Full Text] [Related]
10. [Treatment of circulatory insufficiency with buflomedil chlorhydrate in chronic hemodialysis patients].
Montemurro NE; Damiano M
Clin Ter; 1986 Mar; 116(6):485-9. PubMed ID: 3720235
[No Abstract] [Full Text] [Related]
11. Traveling as a risk factor for venous thromboembolic disease.
Ercegovac UC; Metcalfe TL; Penn BH; Smith KM; Elmore JG
Respir Care; 2006 Oct; 51(10):1177-80. PubMed ID: 17044147
[No Abstract] [Full Text] [Related]
12. [Therapeutic attitude in the presence of thrombosis of the central retinal vein].
Bonamour G
Ann Ocul (Paris); 1968 Feb; 201(2):185-90. PubMed ID: 5674259
[No Abstract] [Full Text] [Related]
13. [Severe Raynaud's phenomenon associated with interferon-beta 1a and fluoxetine].
De Broucker T; Lhote F
Ann Med Interne (Paris); 2000 Sep; 151(5):424-5. PubMed ID: 11033481
[No Abstract] [Full Text] [Related]
14. Ocular vascular accidents.
Little HL
J Okla State Med Assoc; 1971 Apr; 64(4):133-6. PubMed ID: 5572848
[No Abstract] [Full Text] [Related]
15. [Experiences with anticoagulant therapy of chronic arterial occlusion in reconstructive vascular surgery].
Eide M; Koch G
Wien Klin Wochenschr; 1972 May; 84(18):295-7. PubMed ID: 5023446
[No Abstract] [Full Text] [Related]
16. [Drug therapy of atherosclerosis].
Negoiţă CI
Med Interna (Bucur); 1971 Mar; 23(3):325-33. PubMed ID: 5574929
[No Abstract] [Full Text] [Related]
17. Paniverine of a new type for the management of obliterative arterial diseases.
Bugár-Mészáros K; Fonó J
Ther Hung; 1965; 13(4):151-5. PubMed ID: 5864163
[No Abstract] [Full Text] [Related]
18. [Treatment of sudden perception deafness with clarificants and anticoagulants].
Debain JJ
Ann Otolaryngol Chir Cervicofac; 1971 Dec; 88(12):668-72. PubMed ID: 5150487
[No Abstract] [Full Text] [Related]
19. Heparins in the new millennium: will unfractionated heparin survive? Introduction.
McClatchey KD; Galvin HM; Galvin RM
Semin Thromb Hemost; 2000; 26 Suppl 1():3-4. PubMed ID: 11011801
[No Abstract] [Full Text] [Related]
20. [Anticoagulants. 43].
Striegler G
Pharm Prax; 1969 Dec; 12():279-87. PubMed ID: 4191772
[No Abstract] [Full Text] [Related]
[Next] [New Search]
